Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지

The Y153H Variant of the STOX1 Gene in Korean Patients with Preeclampsia

  • Kim, Shin-Young (Laboratory of Medical Genetics, Cheil General Hospital and Women's Healthcare Center) ;
  • Park, So-Yeon (Laboratory of Medical Genetics, Cheil General Hospital and Women's Healthcare Center) ;
  • Lim, Ji-Hyae (Laboratory of Medical Genetics, Cheil General Hospital and Women's Healthcare Center) ;
  • Yang, Jae-Hyug (Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Kim, Moon-Young (Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Park, Hyun-Young (Division of Cardiovascular Disease, Center for Biomedical Sciences, National Institute of Health) ;
  • Lee, Kwang-Soo (Division of Cardiovascular Disease, Center for Biomedical Sciences, National Institute of Health) ;
  • Kim, Young-Ju (Department of Obstetrics and Gynecology, Ewha Medical Research Institue, College of Medicine, Ewha Womans' University) ;
  • Ryu, Hyun-Mee (Laboratory of Medical Genetics, Cheil General Hospital and Women's Healthcare Center)
  • Received : 2009.06.01
  • Accepted : 2009.06.22
  • Published : 2009.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Preeclampsia is a multifactorial disorder with genetic and environmental components. Recently, the STOX1 gene, identified as a candidate gene for preeclampsia in Dutch women, has been shown to be placentally expressed and subject to imprinting with preferential transmission of the maternal allele. The purpose of this study is to investigate whether there is an association between the STOX1 Y153H variation and preeclampsia in Korean pregnant women. Materials and Methods: This study involved 202 preeclamptic and 204 healthy pregnant women who were genotyped for the Y153H variant of the STOX1 gene using a commercially available SNapShot assay kit and an ABI Prism 3730 DNA Analyzer. Results: There were no significant differences in genotype frequencies of the Y153H variant of the STOX1 gene between preeclamptic patients and normal controls (P>0.05). The H allele frequency of the STOX1 Y153H variation was similar in patients with preeclampsia (87.1%) and in normal controls (86.5%). In addition, multiple logistic regression analysis showed that the YH, HH, and YH/HH genotypes were not associated with an increased risk of preeclampsia when compared to the YY genotype. Conclusion: This is the first study to characterize the Y153H variant of the STOX1 gene in Korean patients with preeclampsia. We found no differences in the genotype and allele frequencies between preeclamptic and normal pregnancies. Although limited by a relatively small sample size, our study suggests that the STOX1 Y153H variation is not associated with the development of preeclampsia in Korean pregnant women.

목 적: 자간전증은 유전적 환경적 요인에 의해 발생하는 다요인성 질환이다. 최근 네덜란드 산모에서의 자간전증 후보 유전자로 확인된 STOX1 유전자는 태반에서 발현되며 모계 대립유전자의 선택적 유전에 의해 각인된다. 본 연구에서는 STOX1 유전자의 단일염기변이형 부위인 Y153H와 한국인 자간전증의 연관성에 대하여 알아보고자 하였다. 대상 및 방법: 자간전증 산모 202과 임신기간 동안 자간전증이 발생하지 않은 정상 산모 204명의 혈액으로부터STOX1 유전자의 Y153H 변이 양상을 SNapShot assay kit와 ABI Prism 3730 DNA analyzer를 사용하여 분석하였다. 결과: STOX1 Y153H 변이의 유전자형 빈도는 자간전증환자군과 정상 대조군 간에 유의한 차이가 없었다(P>0.05). 또한 자간전증 환자군(87.1%)에서 대립유전자형인 H의 빈도도 정상 대조군(86.5%)과 유사하였다. 다중회귀분석결과 YH, HH, YH/HH 유전자형들은 자간전증 발생 위험에 있어서 연관성이 없었다. 결 론: 본 연구진은 처음으로 한국인 자간전증 환자에서 STOX1 유전자의 Y153H 변이형의 특징을 파악 하였다. 연구결과 자간전증 산모와 정상 산모 간의 유전자형과 대립유전자형의 빈도는 차이가 없었다. 비록 실험 대상군의 수적인 제한이 있지만, 이상의 결과를 통해서 한국인에서 STOX1 유전자의 Y153H 변이형은 자간전증과 연관성이 없는 것으로 사료된다.

Keywords